|
1
|
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
|
Proc Natl Acad Sci U S A
|
1995
|
3.54
|
|
2
|
Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile.
|
Arthritis Rheum
|
2001
|
2.08
|
|
3
|
Evidence of hypoxic areas within the arterial wall in vivo.
|
Arterioscler Thromb Vasc Biol
|
1999
|
1.58
|
|
4
|
Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis.
|
J Intern Med
|
2008
|
1.49
|
|
5
|
Composition of coronary plaques obtained by directional atherectomy in stable angina: its relation to serum lipids and statin treatment.
|
J Intern Med
|
2006
|
1.41
|
|
6
|
Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis.
|
Stroke
|
1997
|
1.31
|
|
7
|
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
|
Diabetes
|
2003
|
1.28
|
|
8
|
Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis.
|
Atherosclerosis
|
1998
|
1.24
|
|
9
|
Pulse-chase studies of the synthesis and intracellular transport of apolipoprotein B-100 in Hep G2 cells.
|
J Biol Chem
|
1986
|
1.19
|
|
10
|
Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system.
|
Atherosclerosis
|
1996
|
1.18
|
|
11
|
Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production.
|
Arterioscler Thromb Vasc Biol
|
1997
|
1.16
|
|
12
|
Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages.
|
J Clin Invest
|
1996
|
1.16
|
|
13
|
Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations.
|
Arterioscler Thromb
|
1993
|
1.14
|
|
14
|
Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room.
|
Am J Cardiol
|
1991
|
1.12
|
|
15
|
Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence.
|
Arterioscler Thromb
|
1993
|
1.09
|
|
16
|
The nicotine inhaler in smoking cessation.
|
Arch Intern Med
|
1997
|
1.08
|
|
17
|
Studies on the assembly of apo B-100-containing lipoproteins in HepG2 cells.
|
J Biol Chem
|
1988
|
1.07
|
|
18
|
Arterial wall thickness in familial hypercholesterolemia. Ultrasound measurement of intima-media thickness in the common carotid artery.
|
Arterioscler Thromb
|
1992
|
1.07
|
|
19
|
Identification and analysis of macrophage-derived foam cells from human atherosclerotic lesions by using a "mock" FL3 channel in flow cytometry.
|
Cytometry
|
1997
|
1.07
|
|
20
|
The assembly and secretion of apoB 100 containing lipoproteins in Hep G2 cells. Evidence for different sites for protein synthesis and lipoprotein assembly.
|
J Biol Chem
|
1990
|
1.07
|
|
21
|
Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes.
|
J Intern Med
|
2004
|
1.06
|
|
22
|
Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.
|
J Lipid Res
|
1990
|
1.05
|
|
23
|
15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1alpha.
|
Eur J Clin Invest
|
2009
|
1.03
|
|
24
|
Lysophosphatidylcholine induces the production of IL-1beta by human monocytes.
|
Atherosclerosis
|
1998
|
1.02
|
|
25
|
Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages.
|
J Clin Invest
|
1996
|
1.02
|
|
26
|
Role of the low density lipoprotein receptor in penetration of low density lipoprotein into rabbit aortic wall.
|
Arteriosclerosis
|
1985
|
1.01
|
|
27
|
Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction.
|
Arteriosclerosis
|
1981
|
0.99
|
|
28
|
Oxysterols induce interleukin-1beta production in human macrophages.
|
Eur J Clin Invest
|
2002
|
0.97
|
|
29
|
Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study.
|
Arch Intern Med
|
1994
|
0.96
|
|
30
|
Cholesterol: a renal risk factor in diabetic nephropathy?
|
Am J Kidney Dis
|
1993
|
0.94
|
|
31
|
Molecular cloning of human apolipoprotein B cDNA.
|
Nucleic Acids Res
|
1985
|
0.93
|
|
32
|
Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance.
|
Diabetologia
|
2004
|
0.93
|
|
33
|
Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2).
|
Arterioscler Thromb Vasc Biol
|
2001
|
0.92
|
|
34
|
On quantifying plaque size and intima-media thickness in carotid and femoral arteries. Comments on results from a prospective ultrasound study in patients with familial hypercholesterolemia.
|
Arterioscler Thromb Vasc Biol
|
1996
|
0.92
|
|
35
|
Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta.
|
J Clin Invest
|
1993
|
0.91
|
|
36
|
Pulse-chase studies of the synthesis of apolipoprotein B in a human hepatoma cell line, Hep G2.
|
Eur J Biochem
|
1985
|
0.90
|
|
37
|
Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: relevance to progression of atherosclerosis.
|
Circulation
|
2000
|
0.90
|
|
38
|
Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men.
|
Atherosclerosis
|
1980
|
0.90
|
|
39
|
Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix.
|
Arterioscler Thromb Vasc Biol
|
1999
|
0.90
|
|
40
|
Mapping of ATP, glucose, glycogen, and lactate concentrations within the arterial wall.
|
Arterioscler Thromb Vasc Biol
|
2003
|
0.90
|
|
41
|
Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing.
|
J Intern Med
|
2014
|
0.87
|
|
42
|
C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.
|
J Intern Med
|
2007
|
0.87
|
|
43
|
Modifications of low-density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulfate.
|
Biochim Biophys Acta
|
1991
|
0.87
|
|
44
|
Isolation of cell populations from arterial tissue, using monoclonal antibodies and magnetic microspheres.
|
Atherosclerosis
|
1991
|
0.87
|
|
45
|
Structure and biosynthesis of apolipoprotein B.
|
Am Heart J
|
1987
|
0.87
|
|
46
|
Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery.
|
Atherosclerosis
|
1998
|
0.87
|
|
47
|
A common polymorphism in the interleukin-6 gene promoter is associated with overweight.
|
Int J Obes Relat Metab Disord
|
2004
|
0.86
|
|
48
|
Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia.
|
Arterioscler Thromb Vasc Biol
|
1998
|
0.85
|
|
49
|
Post-transcriptional regulation of VEGF expression by oxidised LDL in human macrophages.
|
Eur J Clin Invest
|
2002
|
0.85
|
|
50
|
Serum lipids and apolipoprotein levels in women with acute myocardial infarction.
|
Arteriosclerosis
|
1989
|
0.84
|
|
51
|
Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis.
|
Arterioscler Thromb Vasc Biol
|
1997
|
0.84
|
|
52
|
Evidence for a structural relationship between apoB75kDa and human plasma apolipoprotein B 100, from translation of human liver mRNA in vitro and immunochemical studies with monoclonal and polyclonal antibodies.
|
Eur J Biochem
|
1984
|
0.84
|
|
53
|
Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy.
|
Clin Endocrinol (Oxf)
|
1994
|
0.84
|
|
54
|
Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB/E receptor.
|
Arterioscler Thromb Vasc Biol
|
1997
|
0.84
|
|
55
|
Lack of correlation between the apolipoprotein B XbaI polymorphism and blood lipid levels in a Swedish population.
|
Atherosclerosis
|
1989
|
0.83
|
|
56
|
Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
|
Clin Sci (Lond)
|
2001
|
0.83
|
|
57
|
Platelet function in patients with familial hypertriglyceridemia: evidence that platelet reactivity is modulated by apolipoprotein E content of very-low-density lipoprotein particles.
|
Metabolism
|
2000
|
0.82
|
|
58
|
Butylated hydroxytoluene and N-acetylcysteine attenuates tumor necrosis factor-alpha (TNF-alpha) secretion and TNF-alpha mRNA expression in alveolar macrophages from human lung transplant recipients in vitro.
|
Transplantation
|
1998
|
0.82
|
|
59
|
Increased lipolysis by secretory phospholipase A(2) group V of lipoproteins in diabetic dyslipidaemia.
|
J Intern Med
|
2008
|
0.82
|
|
60
|
Stoichiometric binding of apolipoprotein B-specific monoclonal antibodies to low density lipoproteins.
|
J Biol Chem
|
1985
|
0.82
|
|
61
|
Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans.
|
J Lipid Res
|
1991
|
0.82
|
|
62
|
Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease.
|
J Intern Med
|
2002
|
0.82
|
|
63
|
Genetic characterization of Swedish patients with familial hypercholesterolemia: a heterogeneous pattern of mutations in the LDL receptor gene.
|
Atherosclerosis
|
2002
|
0.82
|
|
64
|
Cholesterol reduction and clinical benefit. Are there limits to our expectations?
|
Arterioscler Thromb Vasc Biol
|
1997
|
0.82
|
|
65
|
A method for the assessment of hypoxia in the arterial wall, with potential application in vivo.
|
Arterioscler Thromb Vasc Biol
|
1996
|
0.81
|
|
66
|
Alphalipoprotein cholesterol levels in relation to acute myocardial infarction and its risk factors.
|
Scand J Clin Lab Invest
|
1980
|
0.81
|
|
67
|
Serum triglycerides and HDL cholesterol--major predictors of long-term survival after coronary surgery.
|
Eur Heart J
|
1994
|
0.81
|
|
68
|
LDL particle size in relation to intima-media thickness and plaque occurrence in the carotid and femoral arteries in patients with hypercholesterolaemia.
|
J Intern Med
|
2000
|
0.81
|
|
69
|
25-hydroxycholesterol induces lipopolysaccharide-tolerance and decreases a lipopolysaccharide-induced TNF-alpha secretion in macrophages.
|
Atherosclerosis
|
2001
|
0.81
|
|
70
|
Human liver RNA-programmed in vitro synthesis of a polypeptide related to human apolipoprotein B.
|
FEBS Lett
|
1983
|
0.81
|
|
71
|
RFLPs for the human apolipoprotein B gene: HincII and PvuII.
|
Nucleic Acids Res
|
1986
|
0.81
|
|
72
|
Acute supplementation with the nitric oxide precursor L-arginine does not improve cardiovascular performance in patients with hypercholesterolemia.
|
Atherosclerosis
|
1995
|
0.81
|
|
73
|
A bioluminescence method for the mapping of local ATP concentrations within the arterial wall, with potential to assess the in vivo situation.
|
Arterioscler Thromb Vasc Biol
|
1999
|
0.80
|
|
74
|
Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy.
|
J Intern Med
|
1993
|
0.80
|
|
75
|
Measurement of antioxidant activity in lipoproteins using enhanced chemiluminescence.
|
Atherosclerosis
|
1994
|
0.80
|
|
76
|
Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity.
|
Metabolism
|
1996
|
0.80
|
|
77
|
Effects of anti-hypertensive therapy on serum lipoproteins. Treatment with metoprolol, propranolol and hydrochlorothiazide.
|
Artery
|
1983
|
0.80
|
|
78
|
One-year mortality rate after discharge from hospital in relation to whether or not a confirmed myocardial infarction was developed.
|
Int J Cardiol
|
1991
|
0.79
|
|
79
|
A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men.
|
Growth Horm IGF Res
|
2000
|
0.79
|
|
80
|
Glucose impairs B-1 cell function in diabetes.
|
Clin Exp Immunol
|
2013
|
0.79
|
|
81
|
Characteristics and prognosis of patients with acute myocardial infarction in relation to whether they were treated in the coronary care unit or in another ward.
|
Cardiology
|
1992
|
0.79
|
|
82
|
Aortic intimal lipid content and serum lipoproteins in patients undergoing coronary by-pass surgery as related to clinical prognosis.
|
Atherosclerosis
|
1988
|
0.79
|
|
83
|
Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction.
|
Eur J Clin Invest
|
1989
|
0.78
|
|
84
|
Computerized measurement of LDL particle size in human serum. Reproducibility studies and evaluation of LDL particle size in relation to metabolic variables and the occurrence of atherosclerosis.
|
Scand J Clin Lab Invest
|
1999
|
0.78
|
|
85
|
Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.
|
J Intern Med
|
2007
|
0.78
|
|
86
|
Low frequency of the common Norwegian and Finnish LDL-receptor mutations in Swedish patients with familial hypercholesterolaemia.
|
J Intern Med
|
1998
|
0.78
|
|
87
|
Inhibitory effects of N-acetylcysteine on scavenger receptor class A expression in human macrophages.
|
J Intern Med
|
2002
|
0.78
|
|
88
|
LDL-associated apolipoprotein J and lysozyme are associated with atherogenic properties of LDL found in type 2 diabetes and the metabolic syndrome.
|
J Intern Med
|
2011
|
0.78
|
|
89
|
Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia.
|
J Intern Med
|
2000
|
0.78
|
|
90
|
Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors. Apolipoprotein A-I levels in male survivors of myocardial infarction.
|
Atherosclerosis
|
1980
|
0.78
|
|
91
|
Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men.
|
Clin Endocrinol (Oxf)
|
1995
|
0.78
|
|
92
|
Comparison of antioxidant activity in lipoprotein fractions from insulin-dependent diabetics and healthy controls.
|
Atherosclerosis
|
1997
|
0.78
|
|
93
|
Seasonal variations in serum lipid and apolipoprotein levels evaluated by periodic regression analyses.
|
J Chronic Dis
|
1982
|
0.77
|
|
94
|
Effect of short-term beta blockade on serum lipid levels and on the interaction of LDL with human arterial proteoglycans.
|
J Clin Pharmacol
|
1990
|
0.77
|
|
95
|
Frontiers in cardiovascular science. Quantitative measurements of atherosclerotic manifestations in humans.
|
Arterioscler Thromb
|
1992
|
0.77
|
|
96
|
Occurrence of angina pectoris prior to acute myocardial infarction and its relation to prognosis.
|
Eur Heart J
|
1993
|
0.77
|
|
97
|
Prognosis in hypertensives with acute myocardial infarction.
|
J Hypertens
|
1992
|
0.77
|
|
98
|
Growth hormone (GH) therapy in GH-deficient adults influences the response to a dietary load of cholesterol and saturated fat in terms of cholesterol synthesis, but not serum low density lipoprotein cholesterol levels.
|
J Clin Endocrinol Metab
|
1999
|
0.76
|
|
99
|
Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a).
|
J Clin Endocrinol Metab
|
1999
|
0.76
|
|
100
|
Increased Interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness.
|
Clin Endocrinol (Oxf)
|
2003
|
0.76
|
|
101
|
Guidelines on CVD prevention: confusing or complementary?
|
Atherosclerosis
|
2012
|
0.76
|
|
102
|
Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty.
|
Eur Heart J
|
1991
|
0.76
|
|
103
|
Fatty acids modulate the effect of darglitazone on macrophage CD36 expression.
|
Eur J Clin Invest
|
2003
|
0.75
|
|
104
|
Intima-media thickness after cholesterol lowering in familial hypercholesterolemia. A three-year ultrasound study of common carotid and femoral arteries.
|
Atherosclerosis
|
1995
|
0.75
|
|
105
|
Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes.
|
Arterioscler Thromb Vasc Biol
|
1995
|
0.75
|
|
106
|
Direct assessment of lipoprotein outflow from in vivo-labeled arterial tissue as determined in an in vitro perfusion system.
|
Arterioscler Thromb Vasc Biol
|
1998
|
0.75
|
|
107
|
Transfer of lipoproteins from plasma to the cell populations of the normal and atherosclerotic arterial tissue.
|
Eur Heart J
|
1990
|
0.75
|
|
108
|
Atherosclerosis basic mechanisms.
|
Acta Med Scand Suppl
|
1986
|
0.75
|
|
109
|
Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men.
|
Clin Endocrinol (Oxf)
|
1994
|
0.75
|
|
110
|
Apolipoprotein B in human aortic biopsies in relation to serum lipids and lipoproteins.
|
Atherosclerosis
|
1989
|
0.75
|
|
111
|
There is no effect on remodeling of vascular wall 4 weeks after local delivery of antithrombin in a porcine model of coronary overstretching.
|
Coron Artery Dis
|
2001
|
0.75
|
|
112
|
Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors--determination of apolipoprotein D.
|
Atherosclerosis
|
1980
|
0.75
|
|
113
|
[Drug treatment of hypercholesterolemia. Confusing discrepancies in guidelines of an advertising campaign].
|
Lakartidningen
|
1990
|
0.75
|
|
114
|
Time-resolved fluorometry in the genetic diagnosis of familial defective apolipoprotein B-100.
|
J Lipid Res
|
1994
|
0.75
|
|
115
|
[Apolipoprotein B plays a central role in atherogenesis and lipid metabolism].
|
Lakartidningen
|
1989
|
0.75
|
|
116
|
Local delivery of antithrombin inhibits platelet deposition after balloon injury in a porcine coronary model.
|
Coron Artery Dis
|
1998
|
0.75
|
|
117
|
Quantitation of human serum apolipoprotein A-I by electroimmunoassay. Studies on some techniques for standardization of the assay and determination of serum apolipoprotein A-I levels in a random population sample of middle-aged men.
|
Scand J Clin Lab Invest
|
1980
|
0.75
|
|
118
|
A new microimmunoassay for apolipoprotein B in arterial tissue. Studies on peroperative human biopsies.
|
Atherosclerosis
|
1986
|
0.75
|
|
119
|
Arterial cholesterol and DNA contents in relation to serum lipids and apolipoproteins. Studies on cystic artery biopsies.
|
Atherosclerosis
|
1982
|
0.75
|
|
120
|
Biochemical typing of hyperlipoproteinemia. The development of a nomogram.
|
Clin Chim Acta
|
1975
|
0.75
|
|
121
|
Effects of injury on apoB kinetics and concentration in rabbit aorta.
|
Arterioscler Thromb Vasc Biol
|
1995
|
0.75
|
|
122
|
Lecithin : cholesterol acyl transfer (LACT) and fatty acid composition of lecithin and cholesterol esters in young male myocardial infarction survivors.
|
Atherosclerosis
|
1979
|
0.75
|
|
123
|
Low-density lipoprotein (LDL) binds to a G-protein coupled receptor in human platelets. Evidence that the proaggregatory effect induced by LDL is modulated by down-regulation of binding sites and desensitization of its mediated signaling.
|
Atherosclerosis
|
2001
|
0.75
|
|
124
|
Pathogenesis and treatment of diabetic vascular disease - illustrated by two cases.
|
J Intern Med
|
2006
|
0.75
|
|
125
|
Risk indicators for recurrence among patients with coronary artery disease. Problems associated with their modification.
|
Scand Cardiovasc J
|
1998
|
0.75
|
|
126
|
Alphalipoprotein cholesterol and arterial cholesterol in human uterine arteries.
|
Artery
|
1980
|
0.75
|
|
127
|
Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism.
|
Invest Urol
|
1977
|
0.75
|
|
128
|
[Quantitative measurement of atherosclerosis. Development of ultrasound techniques is worth while].
|
Lakartidningen
|
1993
|
0.75
|
|
129
|
Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans.
|
Eur J Clin Invest
|
1996
|
0.75
|
|
130
|
Skin cholesterol and DNA in young patients with myocardial infarction.
|
Acta Med Scand
|
1980
|
0.75
|
|
131
|
Binding parameters and concentration modulate formation of complexes between LDL and arterial proteoglycans in serum.
|
Atherosclerosis
|
1989
|
0.75
|
|
132
|
Quantification of plasma lipids and apolipoproteins in British Halflop rabbits. A comparison between normocholesterolemic rabbits, hypercholesterolemic rabbits (modified WHHL rabbits) and rabbits fed an atherogenic diet.
|
Atherosclerosis
|
1988
|
0.75
|